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Editorial Comment 
Left Ventricular Mechanical 
Efficiency in Coronary 
Artery Disease* 
JOEL S. KARLINER, MD, FACC 
San Francisco, California 
Few clinical studies have focused on mechanical efficiency 
as a measure of left ventricular pump performance, partic•
ularly in the clinical setting. This is because the efficiency 
of a pumping chamber must be determined by measuring 
both the external work performed by that chamber and its 
energy expenditure. The former requires some measure of 
left ventricular work which can be obtained by angiographic 
and hemodynamic measurements, while the latter requires 
some measurement of myocardial oxygen consumption. Ni•
chols et al. (1) have performed these complex measurements 
in three groups of patients: I) those with normal coronary 
arteries, two of whom had electrocardiographic abnormal•
ities (left bundle branch block and left ventricular hyper•
trophy); 2) those with angiographic evidence of coronary 
artery disease who had exertional angina pectoris; and 3) 
those with angiographically proved coronary heart disease 
and a previous myocardial infarction associated with seg•
mental wall motion abnormalities on left ventriculography. 
Their findings indicate that patients with coronary artery 
disease but without myocardial infarction exhibit normal 
left ventricular myocardial oxygen consumption and normal 
mechanical efficiency at rest, whereas patients with previous 
myocardial infarction exhibit significantly reduced effi•
ciency because left ventricular work is diminished in the 
presence of normal myocardial oxygen consumption. As 
might be anticipated, reduced efficiency after myocardial 
infarction correlated well with reduced ejection phase in•
dexes of left ventricular performance. As the investigators 
indicate, myocardial blood flow was reduced at rest in the 
patients with coronary artery disease, but total left ventric•
ular flow was not reduced because of augmentation of left 
ventricular mass, resulting in no significant difference in 
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myocardial oxygen consumption among the three patient 
groups. 
Questions requiring answers in the future. Because 
of the technical complexity of these studies and the limi•
tations of methodology, this study could not address certain 
questions, whose answers would provide additional useful 
fundamental physiologic information. Thus, all studies were 
conducted at rest and one would like to know what happens 
to global efficiency in patients with chronic ischemic heart 
disease during exercise. In many patients. a reduction in 
mechanical efficiency would be anticipated as wall motion 
abnormalities developed and ejection fraction declined dur•
ing and immediately after isotonic exercise. As the authors 
indicate, only total, and not regional. myocardial oxygen 
consumption was measured; segmental work and power also 
were not measured. One would predict that regional myo•
cardial efficiency might be reduced. either at rest or certainly 
with exercise. in many patients with normal efficiency at 
rest. The investigators also assumed that left ventricular 
hypertrophy was uniform on the basis of measurements of 
wall thickness in the equatorial plane. It is likely. however, 
that the left ventricle exhibits nonuniform thickness, par•
ticularly in areas of abnormal wall motion. This points to 
the potential utility of regional analysis of various measures 
of left ventricular pump performance, including myocardial 
mechanical efficiency. 
The effects of drugs, particularly beta-adrenergic block•
ers, are also ullcertain. Varying numbers of patients in each 
group were taking propranolol. Even though this agent was 
withheld on the day of the study. sufficient tissue levels of 
the drug could have been present to influence the result of 
the study, either by altering myocardial blood flow or by 
affecting global ejection phase indexes of left ventricular 
performance. 
Recent studies have also indicated that myocardial me•
tabolism, particularly lactate metabolism, may be abnormal 
in patients with coronary artery disease despite the absence 
of overt ischemia (2.3). Thus. myocardial lactate production 
is inversely proportional to free fatty acid levels, and a 
significant amount of lactate can be released by the myo•
cardium at a time when the chemical analysis of the arterial•
coronary sinus difference indicates global myocardial ex•
traction of this metabolite (2,3). Further, recent evidence 
indicates that the ionic contrast medium used in this study 
can significantly alter myocardial metabolism by increasing 
the free fatty uptake of the myocardium while decreasing 
the myocardial uptake of glucose and lactate (4). In the 
future. studies evaluating left ventricular pump performance 
by angiographic means may be better carried out using non•
ionic contrast agents. which exhibit considerably less myo•
cardial toxicity. Nevertheless. the investigation by Nichols 
et al. has provided an important standard against which 
future studies will be measured. 
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